GlobalData on MSN15d
JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400mEli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.
Jan 14 (Reuters) - Eli Lilly's (LLY.N), opens new tab stock ... Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree ...
7d
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback